Redpoint Bio logo

RPBC - Redpoint Bio Share Price

$0 0.0  0.0%

Last Trade - 23/07/19

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £379k
Position in Universe th / 6651
Bullish
Bearish
Unlock RPBC Revenue
Momentum
Relative Strength (%)
1m +1.72%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2006 2007 2008 2009 2010 2011 2012E 2013E CAGR / Avg
0.000 2.23 4.00 1.87 1.24 0.53
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2012, Redpoint BioCorporation revenues was not reported. Net loss decreased68% to $208K. Lower net loss reflects Research anddevelopment decrease from $892K (expense) to $0K, Interestexpense decrease from $35K (expense) to $0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

RPBC Revenue Unlock RPBC Revenue

Net Income

RPBC Net Income Unlock RPBC Revenue

Normalised EPS

RPBC Normalised EPS Unlock RPBC Revenue

PE Ratio Range

RPBC PE Ratio Range Unlock RPBC Revenue

Dividend Yield Range

RPBC Dividend Yield Range Unlock RPBC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
RPBC EPS Forecasts Unlock RPBC Revenue
Profile Summary

Redpoint Bio Corporation is engaged in the development of healthy foods and beverages, and new approaches to the treatment of diabetes and obesity. The Company offers RP44, an all-natural sweetness enhancer. The Company's product, RP44, is used in flavor systems in beverages, dairy products, confectionary products, snack products and bakery products. RP44 amplifies the existing sugary sweetness in a food or beverage so that less sweetener is required, while retaining the clean sweet taste that is associated with sugar.

Directors
Last Annual December 31st, 2011
Last Interim June 30th, 2012
Incorporated August 16, 1995
Public Since October 31, 1988
No. of Shareholders: 229
No. of Employees: n/a
Sector Consumer Defensives
Industry Food & Tobacco
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 79,914,789
Free Float (0.0%)
Eligible for
ISAs
SIPPs
RPBC Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for RPBC
Upcoming Events for RPBC
Frequently Asked Questions for Redpoint Bio
What is the Redpoint Bio share price?

As of 23/07/19, shares in Redpoint Bio are trading at $0, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Redpoint Bio share price performed this year?

Shares in Redpoint Bio are currently trading at $0 and the price has moved by -90% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Redpoint Bio price has moved by -92.2% over the past year.

What are the analyst and broker recommendations for Redpoint Bio?

Of the analysts with advisory recommendations for Redpoint Bio, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Redpoint Bio is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Redpoint Bio next release its financial results?

Redpoint Bio is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2013-06-30
What is the Redpoint Bio dividend yield?

Redpoint Bio does not currently pay a dividend.

Does Redpoint Bio pay a dividend?

Redpoint Bio does not currently pay a dividend.

When does Redpoint Bio next pay dividends?

Redpoint Bio does not currently pay a dividend.

How do I buy Redpoint Bio shares?

To buy shares in Redpoint Bio you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Redpoint Bio?

Shares in Redpoint Bio are currently trading at $0, giving the company a market capitalisation of £n/a.

Where are Redpoint Bio shares listed? Where are Redpoint Bio shares listed?

Here are the trading details for Redpoint Bio:

Country of listing: United States
Exchange: PNK
Ticker Symbol: RPBC
What kind of share is Redpoint Bio?

We were not able to load our ranking data for Redpoint Bio

Is there a Redpoint Bio share price forecast 2021?

We were not able to load any forecast data for Redpoint Bio.

How can I tell whether the Redpoint Bio share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Redpoint Bio. Over the past six months, the relative strength of its shares against the market has been 8.57k%. At the current price of $0, shares in Redpoint Bio are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Redpoint Bio PE Ratio?

We were not able to find PE ratio data for Redpoint Bio.

Who are the key directors of Redpoint Bio?

We were unable to find the directors for Redpoint Bio.

Who are the major shareholders of Redpoint Bio?

Here are the top five shareholders of Redpoint Bio based on the size of their shareholding:

Similar to RPBC
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.